<p>Baseline characteristics for patients on active and placebo intervention stratified by continuous reaction time index (CRT index) at inclusion.</p
Baseline characteristics of the patients in the per-protocol population (n = 54).</p
Baseline characteristics of patients studied, features and interventions during cardiac arrest event...
*<p>A total of 8 subjects (2, 3, 2, and 1 in the placebo, 250 mg q.d., 250 mg b.i.d., and 500 mg q.d...
Baseline characteristics of the patients in the aleglitazar group compared with the placebo group.</...
Baseline characteristics for patients followed up in the control and intervention periods*.</p
<p>Baseline Characteristics for Patients According to Treatment Arm (ITT population).</p
<p>Baseline characteristics in patients sorted by tertiles of baseline C-reactive protein (CRP) conc...
<p>Baseline characteristics of patients randomized to receive atorvastatin or control.</p
<p>Baseline characteristics of patients in the included Randomized Clinical Trials.</p
<p>Baseline characteristics of patients in placebo, metformin at 500 mg/d, and metformin at 1000 mg/...
Baseline characteristics of patients stratified by appropriateness of antibiotic prescription.</p
<p>Baseline characteristics of patients enrolled in the patient navigator intervention.</p
<p>Baseline characteristics of patients randomized to receive aspirin or control.</p
<p>Baseline demographic characteristics of all patients stratified by quintile of PCI rate.</p
<p>Baseline characteristics according to duration of dual antiplatelet therapy.</p
Baseline characteristics of the patients in the per-protocol population (n = 54).</p
Baseline characteristics of patients studied, features and interventions during cardiac arrest event...
*<p>A total of 8 subjects (2, 3, 2, and 1 in the placebo, 250 mg q.d., 250 mg b.i.d., and 500 mg q.d...
Baseline characteristics of the patients in the aleglitazar group compared with the placebo group.</...
Baseline characteristics for patients followed up in the control and intervention periods*.</p
<p>Baseline Characteristics for Patients According to Treatment Arm (ITT population).</p
<p>Baseline characteristics in patients sorted by tertiles of baseline C-reactive protein (CRP) conc...
<p>Baseline characteristics of patients randomized to receive atorvastatin or control.</p
<p>Baseline characteristics of patients in the included Randomized Clinical Trials.</p
<p>Baseline characteristics of patients in placebo, metformin at 500 mg/d, and metformin at 1000 mg/...
Baseline characteristics of patients stratified by appropriateness of antibiotic prescription.</p
<p>Baseline characteristics of patients enrolled in the patient navigator intervention.</p
<p>Baseline characteristics of patients randomized to receive aspirin or control.</p
<p>Baseline demographic characteristics of all patients stratified by quintile of PCI rate.</p
<p>Baseline characteristics according to duration of dual antiplatelet therapy.</p
Baseline characteristics of the patients in the per-protocol population (n = 54).</p
Baseline characteristics of patients studied, features and interventions during cardiac arrest event...
*<p>A total of 8 subjects (2, 3, 2, and 1 in the placebo, 250 mg q.d., 250 mg b.i.d., and 500 mg q.d...